Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole

Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole

BackgroundPolycystic ovary syndrome (PCOS) is a multifaceted disorder that impacts metabolism, reproduction, as well as endocrine function, characterized by excessive levels of androgen and insulin resistance. The gut microbiota has been implicated in the pathogenesis of PCOS. However, the precise m...

Full description

Bibliographic Details
Main Authors:	Yushan Li, Yuchen Zhu, Dan Li, Wen Liu, Yi Zhang, Wei Liu, Chenhong Zhang, Tao Tao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Endocrinology
Subjects:	polycystic ovary syndrome gut microbiota pseudo germ-free glucose metabolism hyperandrogenemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1265152/full

Similar Items

The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
by: Tea Shehu Kolnikaj, et al.
Published: (2024-01-01)

Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
by: Thanyarat Wongwananuruk, et al.
Published: (2024-02-01)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
by: Mardia López-Alarcón, et al.
Published: (2023-08-01)

Factors in the etiopathogenesis of post-adolescent female acne
by: Ezgi Özkur, et al.
Published: (2021-09-01)

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients
by: Shi W, et al.
Published: (2021-10-01)

Effects of intestinal flora on polycystic ovary syndrome
by: Jiayue Liu, et al.
Published: (2023-03-01)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
by: Chuan Xing, et al.
Published: (2022-08-01)

Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism
by: Decio Armanini, et al.
Published: (2022-04-01)

Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
by: Ali Aflatounian, et al.
Published: (2022-11-01)

The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome
by: Nadia B. Pateguana, et al.
Published: (2019-07-01)

Hyperandrogenism by Liquid Chromatography Tandem Mass Spectrometry in PCOS: Focus on Testosterone and Androstenedione
by: Giorgia Grassi, et al.
Published: (2020-12-01)

Comparative analysis of clinical symptoms and biochemical alterations in women with polycystic ovary syndrome: assessing the impact of type 1 diabetes versus non-diabetic controls
by: Maged M. Yassin, et al.
Published: (2024-03-01)

A study on the relation of attention deficit/hyperactivity disorder symptoms with obesity in women with polycystic ovary syndrome
by: Hüda Murat Soyak, et al.
Published: (2023-12-01)

Quercetin and polycystic ovary syndrome
by: Congshun Ma, et al.
Published: (2022-12-01)

Evidence for Increased Expression of SIRT3 Associated with Hyperandrogenism in Granulosa Cells of Non-Obese PCOS Patients
by: Shen Zhang, et al.
Published: (2022-11-01)

Sequential 2.5 mg letrozole/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial
by: Li-Juan Chen, et al.
Published: (2024-01-01)

The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review
by: Salvatore Giovanni Vitale, et al.
Published: (2022-07-01)

Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen
by: Wensu Liu, et al.
Published: (2024-02-01)

The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results
by: Valeria Fedeli, et al.
Published: (2023-03-01)

The effects of metformin on hyperandrogenism and menstrual functions in insulin resistant adolescents with PCOS
by: Recai Pabuçcu, et al.
Published: (2022-05-01)

Marrow adipose tissue is increased in overweight and obese women with PCOS independently of hyperandrogenism related obesity and metabolic disorders
by: Li Xu, et al.
Published: (2023-06-01)

Comparison of Clinical, Biochemical, and Sonological Parameters in Adolescents with and without Polycystic Ovarian Syndrome
by: Sampada Dutt, et al.
Published: (2022-10-01)

Hyperandrogenism as a side effect of anticonvulsants
by: E. V. Tsallagova, et al.
Published: (2018-08-01)

Therapeutic exploration of polyherbal formulation against letrozole induced PCOS rats: A mechanistic approach
by: Arul Balasubramanian, et al.
Published: (2023-05-01)

Effect of Consultation Number on the Assessment and Treatment of Polycystic Ovary Syndrome
by: Wang Y, et al.
Published: (2024-03-01)

Frequency of Hyperandrogenism in Females with Polycystic Ovary Syndrome
by: Sumera Mehnaz, Rahat Akhtar, Nadia Taj
Published: (2021-11-01)

Long-term environmental exposure of darkness induces hyperandrogenism in PCOS via melatonin receptor 1A and aromatase reduction
by: Weiwei Chu, et al.
Published: (2022-10-01)

Effectiveness of Moringa oleifera Leaves on TNF-α Expression, Insulin Levels, Glucose Levels and Follicle Count in Rattus norvegicus PCOS Model
by: Siahaan SCPT, et al.
Published: (2022-10-01)

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
by: Dongxu Wang, et al.
Published: (2023-08-01)

Caffeic acid's role in mitigating polycystic ovary syndrome by countering apoptosis and ER stress triggered by oxidative stress
by: Yi-Fen Chiang, et al.
Published: (2023-10-01)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
by: Zaixin Guo, et al.
Published: (2023-04-01)

Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome
by: Zaixin Guo, et al.
Published: (2023-04-01)

Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome
by: Haolin Zhang, et al.
Published: (2023-01-01)

PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
by: Blazej Meczekalski, et al.
Published: (2023-02-01)

Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics
by: Christoph Haudum, et al.
Published: (2020-06-01)

ApoC3 is expressed in oocytes and increased expression is associated with PCOS progression
by: Jiahe Zhou, et al.
Published: (2023-09-01)

Current Guidelines for Diagnosing PCOS
by: Jacob P. Christ, et al.
Published: (2023-03-01)

Mitochondrial Dysfunction in PCOS: Insights into Reproductive Organ Pathophysiology
by: Kyle M. Siemers, et al.
Published: (2023-08-01)

Dysregulation of immune response in PCOS organ system
by: Jingxuan Wang, et al.
Published: (2023-05-01)

A prospective study examining isolated acne and acne with hyperandrogenic signs in adult females
by: Prekshi Bansal, et al.
Published: (2021-10-01)